IntrinsiQ Specialty Solutions and ION Solutions Provide Independent Oncology, Urology Practices Improved Access to Clinical Trials with the Launch of AdvanceIQ Network


February 13, 2017

image

VALLEY FORGE, Pa.  – Today, IntrinsiQ Specialty Solutions and ION Solutions, both a part of AmerisourceBergen, announced the launch of AdvanceIQ Network, a resource designed to better match independent community oncology and urology practices with clinical trials and research opportunities. Through AdvanceIQ Network, these practices in the U.S. will have a more streamlined approach to identifying, qualifying for and enrolling in targeted clinical trials that offer groundbreaking treatment options for improved patient outcomes.

AdvanceIQ will be made available to more than 5,300 community specialty providers that are a part of ION Solutions and will help eliminate barriers that can prevent participation in clinical trials, including limited resources or time. Practices select the types of research in which they would like to participate, as well as provide access to de-identified patient information. Clinical trial developers can then leverage the AdvanceIQ Network to find practices treating patients who meet specific trial criteria. This offering not only enhances clinical trial matching and leverages new innovative trial recruitment solutions, but also increases patient access to the most advanced therapies and treatment strategies.

“The launch of AdvanceIQ Network addresses one of healthcare’s biggest challenges – access. As specialty care continues to grow, it’s critically important we create new pathways, through both innovat